Hennion & Walsh Asset Management, Inc. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hennion & Walsh Asset Management, Inc. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,759,487
+45959.9%
85,495
+5.2%
0.11%
-50.7%
Q2 2023$3,820
+25.1%
81,233
+11.6%
0.23%
+21.4%
Q1 2023$3,053
+12.7%
72,757
+2.5%
0.19%
+12.0%
Q4 2022$2,709
-99.9%
71,017
-11.7%
0.17%
-19.3%
Q3 2022$3,148,000
+24.3%
80,390
+2.5%
0.21%
+31.8%
Q2 2022$2,533,000
+22.4%
78,418
+25.4%
0.16%
+42.7%
Q1 2022$2,070,000
-6.9%
62,552
+19.6%
0.11%
+0.9%
Q4 2021$2,224,000
+32.5%
52,288
+38.0%
0.11%
+23.9%
Q3 2021$1,679,000
-23.7%
37,895
-2.2%
0.09%
-24.8%
Q2 2021$2,200,000
-24.9%
38,730
-1.1%
0.12%
-33.5%
Q1 2021$2,930,00039,1510.18%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders